Načítá se...
Sequential Exposure of Bortezomib and Vorinostat is Synergistic in Multiple Myeloma Cells
PURPOSE: To examine the combination of bortezomib and vorinostat in multiple myeloma cells (U266) and xenografts, and to assess the nature of their potential interactions with semi-mechanistic pharmacodynamic models and biomarkers. METHODS: U266 proliferation was examined for a range of bortezomib a...
Uloženo v:
| Vydáno v: | Pharm Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826571/ https://ncbi.nlm.nih.gov/pubmed/28101809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-017-2095-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|